← Latest Viking Global portfolio

Viking Global portfolio · 2023-09-30

Form 13F reports holdings as of 2023-09-30 and was filed on 2023-11-14. It is delayed, can omit confidential positions, and is not the manager's current portfolio or fund NAV. Options show reported underlying value—not premium, net exposure, or investment intent.

Disclosed long book

$24.57 billion

Long positions

80

Calls / puts

0 / 0

Top 5 concentration

24.0%

Longs with AI data

0 / 80

Average AI 1Y

PositionKindSharesValueLong weightQuarter changeAI at filing · 1YAI now

VISA INC

VISA INC · COM CL A · 92826C839

LONG 6,971,335 $1.60 billion 6.5% REDUCED

1Y —

5Y —

WORKDAY INC

WORKDAY INC · CL A · 98138H101

LONG 5,236,644 $1.13 billion 4.6% INCREASED

1Y —

5Y —

AMAZON COM INC

AMAZON COM INC · COM · 023135106

LONG 8,749,993 $1.11 billion 4.5% INCREASED

1Y —

5Y —

UNITED PARCEL SERVICE INC

UNITED PARCEL SERVICE INC · CL B · 911312106

LONG 6,660,484 $1.04 billion 4.2% INCREASED

1Y —

5Y —

DANAHER CORPORATION

DANAHER CORPORATION · COM · 235851102

LONG 4,113,043 $1.02 billion 4.2% REDUCED

1Y —

5Y —

MICROSOFT CORP

MICROSOFT CORP · COM · 594918104

LONG 3,024,399 $955.0 million 3.9% INCREASED

1Y —

5Y —

UNITEDHEALTH GROUP INC

UNITEDHEALTH GROUP INC · COM · 91324P102

LONG 1,857,944 $936.8 million 3.8% INCREASED

1Y —

5Y —

META PLATFORMS INC

META PLATFORMS INC · CL A · 30303M102

LONG 3,057,022 $917.7 million 3.7% INCREASED

1Y —

5Y —

API GROUP CORP

API GROUP CORP · COM STK · 00187Y100

LONG 34,199,532 $886.8 million 3.6% UNCHANGED

1Y —

5Y —

GENERAL ELECTRIC CO

GENERAL ELECTRIC CO · COM NEW · 369604301

LONG 7,996,906 $884.1 million 3.6% INCREASED

1Y —

5Y —

ROIVANT SCIENCES LTD

ROIVANT SCIENCES LTD · SHS · G76279101

LONG 73,434,301 $857.7 million 3.5% REDUCED

1Y —

5Y —

BRIDGEBIO PHARMA INC

BRIDGEBIO PHARMA INC · COM · 10806X102

LONG 25,120,991 $662.4 million 2.7% REDUCED

1Y —

5Y —

MCKESSON CORP

MCKESSON CORP · COM · 58155Q103

LONG 1,457,725 $633.9 million 2.6% INCREASED

1Y —

5Y —

FORTIVE CORP

FORTIVE CORP · COM · 34959J108

LONG 8,325,095 $617.4 million 2.5% REDUCED

1Y —

5Y —

HDFC BANK LTD

HDFC BANK LTD · SPONSORED ADS · 40415F101

LONG 10,116,023 $596.9 million 2.4% INCREASED

1Y —

5Y —

AMERIPRISE FINL INC

AMERIPRISE FINL INC · COM · 03076C106

LONG 1,734,018 $571.7 million 2.3% INCREASED

1Y —

5Y —

PHILIP MORRIS INTL INC

PHILIP MORRIS INTL INC · COM · 718172109

LONG 5,971,784 $552.9 million 2.3% REDUCED

1Y —

5Y —

BLOCK INC

BLOCK INC · CL A · 852234103

LONG 12,324,808 $545.5 million 2.2% NEWLY REPORTED

1Y —

5Y —

PPG INDS INC

PPG INDS INC · COM · 693506107

LONG 4,044,244 $524.9 million 2.1% INCREASED

1Y —

5Y —

THERMO FISHER SCIENTIFIC INC

THERMO FISHER SCIENTIFIC INC · COM · 883556102

LONG 899,715 $455.4 million 1.9% INCREASED

1Y —

5Y —

DOORDASH INC

DOORDASH INC · CL A · 25809K105

LONG 5,367,522 $426.6 million 1.7% INCREASED

1Y —

5Y —

FORTINET INC

FORTINET INC · COM · 34959E109

LONG 7,050,550 $413.7 million 1.7% REDUCED

1Y —

5Y —

CADENCE DESIGN SYSTEM INC

CADENCE DESIGN SYSTEM INC · COM · 127387108

LONG 1,653,230 $387.4 million 1.6% REDUCED

1Y —

5Y —

BIOMARIN PHARMACEUTICAL INC

BIOMARIN PHARMACEUTICAL INC · COM · 09061G101

LONG 4,215,456 $373.0 million 1.5% INCREASED

1Y —

5Y —

FREEPORT-MCMORAN INC

FREEPORT-MCMORAN INC · CL B · 35671D857

LONG 9,769,679 $364.3 million 1.5% NEWLY REPORTED

1Y —

5Y —

CSX CORP

CSX CORP · COM · 126408103

LONG 10,640,828 $327.2 million 1.3% REDUCED

1Y —

5Y —

EVEREST GROUP LTD

EVEREST GROUP LTD · COM · G3223R108

LONG 808,459 $300.5 million 1.2% REDUCED

1Y —

5Y —

LULULEMON ATHLETICA INC

LULULEMON ATHLETICA INC · COM · 550021109

LONG 776,515 $299.4 million 1.2% REDUCED

1Y —

5Y —

VALVOLINE INC

VALVOLINE INC · COM · 92047W101

LONG 8,867,163 $285.9 million 1.2% INCREASED

1Y —

5Y —

GINKGO BIOWORKS HOLDINGS INC

GINKGO BIOWORKS HOLDINGS INC · CL A SHS · 37611X100

LONG 143,085,126 $259.0 million 1.1% UNCHANGED

1Y —

5Y —

ROYALTY PHARMA PLC

ROYALTY PHARMA PLC · SHS CLASS A · G7709Q104

LONG 9,464,201 $256.9 million 1.0% REDUCED

1Y —

5Y —

UNUM GROUP

UNUM GROUP · COM · 91529Y106

LONG 4,778,110 $235.0 million 1.0% REDUCED

1Y —

5Y —

EPAM SYS INC

EPAM SYS INC · COM · 29414B104

LONG 918,497 $234.9 million 1.0% INCREASED

1Y —

5Y —

FIVE9 INC

FIVE9 INC · COM · 338307101

LONG 3,593,745 $231.1 million 0.9% INCREASED

1Y —

5Y —

GALLAGHER ARTHUR J & CO

GALLAGHER ARTHUR J & CO · COM · 363576109

LONG 957,820 $218.3 million 0.9% INCREASED

1Y —

5Y —

KARUNA THERAPEUTICS INC

KARUNA THERAPEUTICS INC · COM · 48576A100

LONG 1,131,263 $191.3 million 0.8% INCREASED

1Y —

5Y —

INTUITIVE SURGICAL INC

INTUITIVE SURGICAL INC · COM NEW · 46120E602

LONG 640,983 $187.4 million 0.8% NEWLY REPORTED

1Y —

5Y —

CBRE GROUP INC

CBRE GROUP INC · CL A · 12504L109

LONG 2,504,799 $185.0 million 0.8% REDUCED

1Y —

5Y —

METLIFE INC

METLIFE INC · COM · 59156R108

LONG 2,933,356 $184.5 million 0.8% NEWLY REPORTED

1Y —

5Y —

ADAPTIVE BIOTECHNOLOGIES COR

ADAPTIVE BIOTECHNOLOGIES COR · COM · 00650F109

LONG 29,993,708 $163.5 million 0.7% UNCHANGED

1Y —

5Y —

PROGRESSIVE CORP

PROGRESSIVE CORP · COM · 743315103

LONG 1,145,322 $159.5 million 0.6% INCREASED

1Y —

5Y —

ACADIA HEALTHCARE COMPANY IN

ACADIA HEALTHCARE COMPANY IN · COM · 00404A109

LONG 2,255,213 $158.6 million 0.6% REDUCED

1Y —

5Y —

RAYZEBIO INC

RAYZEBIO INC · COM · 75525N107

LONG 6,642,700 $147.5 million 0.6% NEWLY REPORTED

1Y —

5Y —

SYNOPSYS INC

SYNOPSYS INC · COM · 871607107

LONG 308,059 $141.4 million 0.6% REDUCED

1Y —

5Y —

INTERNATIONAL FLAVORS&FRAGRA

INTERNATIONAL FLAVORS&FRAGRA · COM · 459506101

LONG 2,067,060 $140.9 million 0.6% REDUCED

1Y —

5Y —

INHIBRX INC

INHIBRX INC · COM · 45720L107

LONG 7,150,826 $131.2 million 0.5% INCREASED

1Y —

5Y —

MASTERCARD INCORPORATED

MASTERCARD INCORPORATED · CL A · 57636Q104

LONG 292,288 $115.7 million 0.5% REDUCED

1Y —

5Y —

COLGATE PALMOLIVE CO

COLGATE PALMOLIVE CO · COM · 194162103

LONG 1,424,845 $101.3 million 0.4% INCREASED

1Y —

5Y —

KBR INC

KBR INC · COM · 48242W106

LONG 1,555,209 $91.7 million 0.4% INCREASED

1Y —

5Y —

CNH INDL N V

CNH INDL N V · SHS · N20944109

LONG 6,741,281 $81.6 million 0.3% INCREASED

1Y —

5Y —

GUARDANT HEALTH INC

GUARDANT HEALTH INC · NOTE 11/1 · 40131MAB5

LONG 111,500,000 $77.2 million REDUCED

1Y —

5Y —

DOVER CORP

DOVER CORP · COM · 260003108

LONG 536,587 $74.9 million 0.3% NEWLY REPORTED

1Y —

5Y —

NEWAMSTERDAM PHARMA COMPANY

NEWAMSTERDAM PHARMA COMPANY · ORDINARY SHARES · N62509109

LONG 8,024,565 $74.2 million 0.3% INCREASED

1Y —

5Y —

COUPANG INC

COUPANG INC · CL A · 22266T109

LONG 4,362,544 $74.2 million 0.3% REDUCED

1Y —

5Y —

KEURIG DR PEPPER INC

KEURIG DR PEPPER INC · COM · 49271V100

LONG 2,288,261 $72.2 million 0.3% NEWLY REPORTED

1Y —

5Y —

KE HLDGS INC

KE HLDGS INC · SPONSORED ADS · 482497104

LONG 4,620,000 $71.7 million 0.3% NEWLY REPORTED

1Y —

5Y —

TENET HEALTHCARE CORP

TENET HEALTHCARE CORP · COM NEW · 88033G407

LONG 1,025,840 $67.6 million 0.3% INCREASED

1Y —

5Y —

PHARVARIS N V

PHARVARIS N V · COM · N69605108

LONG 3,231,923 $67.5 million 0.3% UNCHANGED

1Y —

5Y —

ZOOMINFO TECHNOLOGIES INC

ZOOMINFO TECHNOLOGIES INC · COMMON STOCK · 98980F104

LONG 3,754,192 $61.6 million 0.3% INCREASED

1Y —

5Y —

4D MOLECULAR THERAPEUTICS IN

4D MOLECULAR THERAPEUTICS IN · COM · 35104E100

LONG 4,787,914 $61.0 million 0.2% UNCHANGED

1Y —

5Y —

DATADOG INC

DATADOG INC · CL A COM · 23804L103

LONG 668,511 $60.9 million 0.2% REDUCED

1Y —

5Y —

ZAI LAB LTD

ZAI LAB LTD · ADR · 98887Q104

LONG 2,491,003 $60.6 million 0.2% REDUCED

1Y —

5Y —

CONFLUENT INC

CONFLUENT INC · CLASS A COM · 20717M103

LONG 1,983,066 $58.7 million 0.2% NEWLY REPORTED

1Y —

5Y —

BOSTON SCIENTIFIC CORP

BOSTON SCIENTIFIC CORP · COM · 101137107

LONG 1,110,292 $58.6 million 0.2% NEWLY REPORTED

1Y —

5Y —

AMYLYX PHARMACEUTICALS INC

AMYLYX PHARMACEUTICALS INC · COM · 03237H101

LONG 2,962,555 $54.2 million 0.2% UNCHANGED

1Y —

5Y —

VIKING THERAPEUTICS INC

VIKING THERAPEUTICS INC · COM · 92686J106

LONG 4,573,316 $50.6 million 0.2% INCREASED

1Y —

5Y —

MOBILEYE GLOBAL INC

MOBILEYE GLOBAL INC · COMMON CLASS A · 60741F104

LONG 1,011,692 $42.0 million 0.2% NEWLY REPORTED

1Y —

5Y —

DOLLAR GEN CORP NEW

DOLLAR GEN CORP NEW · COM · 256677105

LONG 368,172 $39.0 million 0.2% NEWLY REPORTED

1Y —

5Y —

FOOT LOCKER INC

FOOT LOCKER INC · COM · 344849104

LONG 2,235,456 $38.8 million 0.2% NEWLY REPORTED

1Y —

5Y —

EDGEWISE THERAPEUTICS INC

EDGEWISE THERAPEUTICS INC · COM · 28036F105

LONG 6,159,146 $35.3 million 0.1% INCREASED

1Y —

5Y —

ARM HOLDINGS PLC

ARM HOLDINGS PLC · SPONSORED ADR · 042068205

LONG 600,000 $32.1 million 0.1% NEWLY REPORTED

1Y —

5Y —

DAY ONE BIOPHARMACEUTICALS I

DAY ONE BIOPHARMACEUTICALS I · COM · 23954D109

LONG 2,558,563 $31.4 million 0.1% UNCHANGED

1Y —

5Y —

FARFETCH LTD

FARFETCH LTD · ORD SH CL A · 30744W107

LONG 10,844,009 $22.7 million 0.1% INCREASED

1Y —

5Y —

VERASTEM INC

VERASTEM INC · COM NEW · 92337C203

LONG 2,456,292 $20.0 million 0.1% INCREASED

1Y —

5Y —

RALLYBIO CORP

RALLYBIO CORP · COM · 75120L100

LONG 4,194,777 $14.1 million 0.1% UNCHANGED

1Y —

5Y —

TREVI THERAPEUTICS INC

TREVI THERAPEUTICS INC · COM · 89532M101

LONG 4,400,000 $9.6 million 0.0% UNCHANGED

1Y —

5Y —

PEPGEN INC

PEPGEN INC · COM · 713317105

LONG 1,482,434 $7.5 million 0.0% UNCHANGED

1Y —

5Y —

LIANBIO

LIANBIO · SPONSORED ADS · 53000N108

LONG 3,564,173 $5.3 million 0.0% UNCHANGED

1Y —

5Y —

MAPLEBEAR INC

MAPLEBEAR INC · COM · 565394103

LONG 125,000 $3.7 million 0.0% NEWLY REPORTED

1Y —

5Y —

KINNATE BIOPHARMA INC

KINNATE BIOPHARMA INC · COM · 49705R105

LONG 1,820,462 $2.5 million 0.0% UNCHANGED

1Y —

5Y —

AI outlook values are averages across the latest successful run per covered model at the labeled cutoff. “No longer reported” does not necessarily mean sold; thresholds, confidential treatment, corporate actions, or instrument changes may explain an omission. Reviewed API mapping covers 0.0% of disclosed long-book value; exact editorial CUSIP mappings may add current-only AI coverage on this public page. Research use only. No warranty and not investment advice.